These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8709171)

  • 21. Pharmacokinetics of prulifloxacin. 2nd communication: pharmacokinetics and effect on hepatic drug-metabolizing enzyme activities after repeated administration and transfer into fetus and milk after a single administration in rats.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):285-92. PubMed ID: 9105547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developmental toxicity evaluation of the new fluoroquinolone antibacterial DW-116 in rats.
    Kim JC; Shin DH; Kim SH; Ahn TH; Kang SS; Jang BS; Kim CY; Chung MK
    Teratog Carcinog Mutagen; 2003; Suppl 1():123-36. PubMed ID: 12616603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [52-week oral toxicity study of lactitol (NS-4) in rats followed by 9-week recovery test].
    Okazaki S; Kobayashi J; Tamura K; Nagatani M; Hamasu Y; Sumi N
    J Toxicol Sci; 1994 Nov; 19 Suppl 3():377-404. PubMed ID: 7837295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A 26-week oral repeated dose toxicity study of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate (NS-21), a novel drug for urinary frequency and incontinence, in rats followed by a 9-week recovery test].
    Okasaki K; Baba S; Ikeda H; Chihaya Y; Satake S; Nagata R; Ishibashi S; Iwakura K; Sumi N
    J Toxicol Sci; 1997 Apr; 22 Suppl 1():59-92. PubMed ID: 9170603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [52-week oral toxicity study of lactitol (NS-4) in dogs followed by 9-week recovery test].
    Onishi M; Ueda T; Omachi K; Honda T; Nomura M; Nagata R; Hamasu Y; Sumi N
    J Toxicol Sci; 1994 Nov; 19 Suppl 3():405-27. PubMed ID: 7837296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Twenty-six-week intravenous toxicity study of montirelin hydrate (NS-3) in rats followed by 9-week recovery test].
    Furukawa S; Nishida I; Kikumori M; Taniguchi Y; Nishimori T; Ishibashi S; Iwakura K; Sumi N
    J Toxicol Sci; 1995 Dec; 20 Suppl 2():191-213. PubMed ID: 9019558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A 13-week subacute oral toxicity study of 6-amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl) amino] benzoate dimethanesulfonate (FUT-187) in rats].
    Okazaki S; Todate A; Yamazaki E; Anabuki K; Tamura K; Hoshiya T; Maruden A; Terazawa K
    J Toxicol Sci; 1992 Dec; 17 Suppl 4():17-59. PubMed ID: 1296023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Five-week intravenous toxicity study of montirelin hydrate (NS-3) in rats followed by 4-week recovery test].
    Kikumori M; Nishida I; Kojima M; Taniguchi Y; Yasuhira K; Ishibashi S; Iwakura K; Sumi N
    J Toxicol Sci; 1995 Dec; 20 Suppl 2():171-89. PubMed ID: 9019557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Three months oral repeated dose toxicity of T-3761 in rats].
    Kawamura Y; Nagai A; Yoshida K; Nagasawa M; Kitoh N; Kodama T
    Jpn J Antibiot; 1995 Jun; 48(6):769-89. PubMed ID: 7666581
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cecal torsion in rodents associated with chronic administration of clinafloxacin.
    Courtney CL
    Toxicol Pathol; 2000; 28(5):643-8. PubMed ID: 11026598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of prulifloxacin. 3rd communication: metabolism in rats, dogs and monkeys.
    Okuyama Y; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):293-8. PubMed ID: 9105548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical study of prulifloxacin on infectious enteritis. Japan Research Committee of Prulifloxacin, Research Group on Infectious Enteritis].
    Tomizawa I; Takizawa Y; Nitta Y; Tsunoda T; Fukuda H; Yamaguchi T; Masuda G; Negishi M; Ajisawa A; Murata M; Ohnishi K; Irimajiri S; Obana M; Sajima Y; Sagara H; Kato H; Hosoda S; Banba T; Sasaki M; Yoshikawa K; Nakagawa M; Ohkubo H; Kim Y; Akao M; Fukuyama M
    Kansenshogaku Zasshi; 1996 Jul; 70(7):727-45. PubMed ID: 8797308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subchronic oral toxicity studies with gamma-cyclodextrin in rats.
    Lina BA; Bär A
    Regul Toxicol Pharmacol; 1998 Apr; 27(2):178-88. PubMed ID: 9671573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and safety of NM441, a new quinolone, in healthy male volunteers.
    Nakashima M; Uematsu T; Kosuge K; Okuyama Y; Morino A; Ozaki M; Takebe Y
    J Clin Pharmacol; 1994 Sep; 34(9):930-7. PubMed ID: 7983237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peri- and postnatal developmental toxicity of the fluoroquinolone antibacterial DW-116 in rats.
    Kim JC; Shin DH; Kim SH; Oh KS; Jung YH; Kwon HJ; Yun HI; Shin HC; Chung MK
    Food Chem Toxicol; 2004 Mar; 42(3):389-95. PubMed ID: 14871581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Three months intravenous repeated dose toxicity study of T-3762 in rats].
    Kawamura Y; Kitou N; Nagai A; Sanzen T; Kodama T
    Jpn J Antibiot; 1998 Oct; 51(10):600-23. PubMed ID: 9914951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation among the toxicity profiling (28-days repeated oral dose toxicity), toxicokinetics and tissue distribution data of ulifloxacin, the active metabolite of prulifloxacin in Wistar albino rats.
    Nandi U; Roy B; Das AK; Pal TK
    Environ Toxicol Pharmacol; 2012 Sep; 34(2):588-607. PubMed ID: 22885677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute and subchronic toxicity studies of the new quinolone antibacterial agent irloxacin in rodents.
    Guzmán A; García C; Demestre I
    Arzneimittelforschung; 1999 May; 49(5):448-56. PubMed ID: 10367108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.